April 25, 2019, at 11 pm PT/2 pm ET
23andMe’s Type 2 Diabetes Report
Last month, 23andMe released a new Type 2 Diabetes (T2D) report that informs eligible 23andMe customers about their genetic likelihood of developing T2D. This model was built using genetic and health data from more than 2.5 million 23andMe customers who consented to participate in research.
Join our webinar for healthcare professionals on Thursday, April 25, 11:00am-11:30am PT/2:00-2:30pm ET to learn about the science behind our new report, our Powered by 23andMe Research and how information regarding likelihood of developing T2D is communicated to consumers. We will provide a walkthrough of the consumer experience and answer questions that are submitted during a live Q&A session.
This webinar is intended for healthcare professionals.
Becca Krock, PhD, is a Product Scientist at 23andMe, where she helped develop the Type 2 Diabetes report as well as other reports and product features. She earned her PhD in neuroscience at Stanford University, where she studied the neural mechanisms of visual perception. She completed her BS in Biology at Washington University in St. Louis.
Michael Multhaup, PhD, is a Senior Product Scientist at 23andMe. He specializes in polygenic risk scores and has authored over a dozen trait, wellness and health reports, including 23andMe’s recent Type 2 Diabetes Report. Michael holds a bachelor’s degree in biological sciences from Stanford University, as well as a PhD in biochemistry, cellular and molecular biology from the Johns Hopkins School of Medicine.